Avexitide

Drug identity checked against registry records

Also recorded as exendin 9-39

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Avexitide for Treatment of Post-Bariatric HypoglycemiaNCT06747468AMLXPhase 3Active not recruiting2026-07-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.